About: Apolizumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005, because of toxic effects and lack of efficacy in humans. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia.

Property	Value
dbo:abstract	أبوليزوماب هو جسم مضاد وحيد النسيلة يدرس حالياً ليستخدم في أورام الدم. (ar) Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005, because of toxic effects and lack of efficacy in humans. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. (en)
dbo:casNumber	267227-08-7
dbo:fdaUniiCode	G88KCP51RE
dbo:kegg	D02967
dbo:wikiPageID	8552611 (xsd:integer)
dbo:wikiPageLength	3153 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1092521214 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cancer dbc:Abandoned_drugs dbr:Monoclonal_antibody dbr:HLA-DR dbc:Monoclonal_antibodies dbr:Aseptic_meningitis dbr:Uremia
dbp:atcPrefix	none (en)
dbp:casNumber	267227 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:kegg	D02967 (en)
dbp:mabType	mab (en)
dbp:source	zu/o (en)
dbp:target	HLA-DR beta (en)
dbp:type	mab (en)
dbp:unii	G88KCP51RE (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	457135624 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Keggcite dbt:Monoclonals_for_immune_system dbt:Monoclonal-antibody-stub
dcterms:subject	dbc:Abandoned_drugs dbc:Monoclonal_antibodies
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct
rdfs:comment	أبوليزوماب هو جسم مضاد وحيد النسيلة يدرس حالياً ليستخدم في أورام الدم. (ar) Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005, because of toxic effects and lack of efficacy in humans. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. (en)
rdfs:label	أبوليزوماب (ar) Apolizumab (en)
owl:sameAs	freebase:Apolizumab yago-res:Apolizumab wikidata:Apolizumab dbpedia-ar:Apolizumab https://global.dbpedia.org/id/4RNeY
prov:wasDerivedFrom	wikipedia-en:Apolizumab?oldid=1092521214&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Apolizumab
is dbo:wikiPageWikiLink of	dbr:Index_of_oncology_articles dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_An–Ap
is foaf:primaryTopic of	wikipedia-en:Apolizumab